Bifidobacterium lactis b94 plus inulin for treatment of helicobacter pylori infection in children: Does it increase eradication rate and patient compliance ?

Acta Gastro-Enterologica Belgica

Volumn 78, Issue 3, 2015, Pages 282-286

  Islek, Ali ^a   Sayar, Ersin ^a   Yilmaz, Aygen ^a   Artan, Reha ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

B. lactis; Children; H. pylori eradication; Inulin

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; INULIN; LANSOPRAZOLE; PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL CLEARANCE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS B94; CHILD; CHILDHOOD DISEASE; CHRONIC GASTRITIS; CONTROLLED STUDY; DIARRHEA; DRUG TOLERABILITY; DUODENITIS; EPIGASTRIC BURNING; EPIGASTRIC PAIN; ERUCTATION; FEMALE; HELICOBACTER INFECTION; HUMAN; HYPEREMIA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; METAPLASIA; NAUSEA; PATIENT COMPLIANCE; RAPID UREASE TEST; TASTE DISORDER; VOMITING;

EID: 84944715210     PISSN: 17843227     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rowland M., Bourke B., Drumm B. Helicobacter pylori and Peptic Ulcer Disease. Walker’s Pediatric Gastrointestinal Disease. In: KLEINMAN R.E., GOULET OJ., SANDERSON IR., SHERMAN P.M., SHNEIDER P., VERGANI G.M. (eds). Volume 1, Hamilton, 2008, BC Decker Inc, 2008, 139-152.
2. Kivi, M., Tindberg, Y. Helicobacter pylori occurrence and transmission: A family affair ? Scand. J. Infect. Dis., 2006, 38: 407-417.
3. Vandenplas Y. The role of Helicobacter pylori in paediatrics. Curr. Opinion Infect. Dis., 2001, 14: 315-321.
4. Oderda G., Schherbakov P., Bontems P. Results from the Pediatric European Register for Treatment of Helicobacter pylori (PERTH). Helicobacter, 2007, 12: 150-156.
5. Kadayifçi A., Büyükhatipo glu H., Savas M.C., SIm sek I. Eradication of Helicobacter pylori with triple therapy: An epidemiologic analysis of trends in Turkey over 10 years. Clin. Ther., 2006, 11: 1960-1966.
6. HIll C., Guarner F., ReId G., GIbson G.R., MerensteIn D.J., Pot B. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol., 2014, 11: 506-514.
7. Lorca GL., Wadström T., Valdez G.F., Ljungh A. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr. Microbiol., 2001, 42: 39-44.
8. Mack D.R., Ahrne S., Hyde L., Wei, S. HollIngsworth M.A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut, 2003, 52: 827-833.
9. LIonetti, E. Indrio, F. Pavone, L. Borrelli, G. Cavallo, L. Francavilla, R. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter, 2010, 15: 79-87.
10. Bengmark S. Pre, pro and synbiotics. Curr. Opin. Clin. Nutr. Metab. Care, 2001, 4: 571-579.
11. PacIfIco L., Osborn J.F., Bonci E., Romaggioli, S., Baldini R., Chiesa C. Probiotics for the treatment of Helicobacter pylori infection in children. World J. Gastroenterol., 2014, 20: 673-683.
12. Alsahli M., Michetti P. Lactobacilli for the management of Helicobacter pylori. Nutrition, 2001, 17: 268-269.
13. Goldman C.G., Barrado D.A., Balcarce N. et al. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition, 2006, 22: 984-988.
14. Lionetti E., Miniello V.L., Castellaneta S.P. et al. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment. Pharmacol. Ther., 2006, 24: 1461-1468.
15. Hurduc V., Plesca D., DragomIr D., SajIn M., Vandenplas Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr., 2009, 98: 127-131.
16. Szajewska H., Albrecht P., Topczewska-Cabanek A. Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J. Pediatr. Gastroenterol. Nutr., 2009, 48: 431-436.
17. Sykora J., Valeckova K., Amlerova J. et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of Helicobacter pylori in children: a prospective randomized, double-blind study. J. Clin. Gastroenterol., 2005, 39: 692-698.
18. Wang K.Y., LI S.N., LIu C.S. et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr., 2004, 80: 737-741.
19. de Vrese M., KrIsten H., Rautenberg P., Laue C., SchrezenmeIr J. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J. Dairy Res., 2011, 78: 396-403.
20. Deltenre M., Ntounda R., Jonas C., De Koster E. Eradication of Helicobacter pylori: why does it fail ? Ital. J. Gastroenterol. Hepatol., 1998, 30 (Suppl 3): 326-328.
21. Braegger C., Chmielewska A., Decsi T. et al. Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr., 2011, 52: 238-250.